Terms: = Liver cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
11756 results:
1. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive analysis of the oncogenic and prognostic role of TBC1Ds in human hepatocellular carcinoma.
Zhang P; Zhu L; Pan X
PeerJ; 2024; 12():e17362. PubMed ID: 38766486
[TBL] [Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?
Barone M
World J Gastroenterol; 2024 May; 30(18):2391-2396. PubMed ID: 38764773
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice.
Ling C; Liu SS; Wang YY; Huo GT; Yang YW; Xu N; Wang H; Wu Y; Miao YF; Fu R; Zhao YW; Fan CF
Zool Res; 2024 May; 45(3):551-566. PubMed ID: 38757223
[TBL] [Abstract] [Full Text] [Related]
5. Multimodal Imaging-Guided Synergistic Photodynamic Therapy Using Carbonized Zn/Co Metal-Organic Framework Loaded with Cytotoxin Against liver cancer.
Huang J; Guo L; Huang X; Yu X; Lin L; Jiang X; Bai Z; Li Z
Int J Nanomedicine; 2024; 19():4163-4180. PubMed ID: 38751660
[TBL] [Abstract] [Full Text] [Related]
6. [Current status and challenges of clinical research and development of new drugs for liver diseases].
Shen ZY; Cai XB; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):289-294. PubMed ID: 38733180
[TBL] [Abstract] [Full Text] [Related]
7. Receptor Targeting Using Copolymer-Modified Gold Nanoparticles for pCMV-Luc Gene Delivery to liver cancer Cells In Vitro.
Zenze M; Singh M
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732235
[TBL] [Abstract] [Full Text] [Related]
8. Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat liver Fibrosis.
Smith-Cortinez N; Heegsma J; Podunavac M; Zakarian A; Cardenas JC; Faber KN
Cells; 2024 Apr; 13(9):. PubMed ID: 38727301
[TBL] [Abstract] [Full Text] [Related]
9. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
10. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Iqbal S; Sebhaoui J; Ashraf S; Ozcan M; Kim W; Belmen B; Yeşilyurt G; Hanashalshahaby E; Zhang C; Uhlen M; Boren J; Turkez H; Mardinoglu A
Bioorg Chem; 2024 Jun; 147():107425. PubMed ID: 38714117
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
12. Applications of Pyrrole and Pyridine-based Heterocycles in cancer Diagnosis and treatment.
Tyagi R; Yadav K; Srivastava N; Sagar R
Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
[TBL] [Abstract] [Full Text] [Related]
13. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.
Salim EI; Alabasy MM; Nashar EME; Al-Zahrani NS; Alzahrani MA; Guo Z; Beltagy DM; Shahen M
BMC Complement Med Ther; 2024 May; 24(1):185. PubMed ID: 38711049
[TBL] [Abstract] [Full Text] [Related]
14. Nanoparticle/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma cancer Therapy.
Yang M; Chen W; Gupta D; Mei C; Yang Y; Zhao B; Qiu L; Chen J
Int J Nanomedicine; 2024; 19():3827-3846. PubMed ID: 38708180
[TBL] [Abstract] [Full Text] [Related]
15. ViroISDC: a method for calling integration sites of hepatitis B virus based on feature encoding.
Qiao L; Li C; Lin W; He X; Mi J; Tong Y; Gao J
BMC Bioinformatics; 2024 May; 25(1):177. PubMed ID: 38704528
[TBL] [Abstract] [Full Text] [Related]
16. Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
Yuan Y; Xu J; Jiang Q; Yang C; Wang N; Liu X; Piao HL; Lu S; Zhang X; Han L; Liu Z; Cai J; Liu F; Chen S; Liu J
J Exp Clin Cancer Res; 2024 May; 43(1):133. PubMed ID: 38698462
[TBL] [Abstract] [Full Text] [Related]
17. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.
Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY
Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648
[TBL] [Abstract] [Full Text] [Related]
18. Mesenchymal stromal/stem cells promote intestinal epithelium regeneration after chemotherapy-induced damage.
Yetkin-Arik B; Jansen SA; Varderidou-Minasian S; Westendorp B; Skarp KP; Altelaar M; Lindemans CA; Lorenowicz MJ
Stem Cell Res Ther; 2024 Apr; 15(1):125. PubMed ID: 38679715
[TBL] [Abstract] [Full Text] [Related]
19. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway.
Zhao C; Zheng L; Ma Y; Zhang Y; Yue C; Gu F; Niu G; Chen Y
Int J Immunopathol Pharmacol; 2024; 38():3946320241249445. PubMed ID: 38679570
[TBL] [Abstract] [Full Text] [Related]
20. Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses.
March S; Nerurkar N; Jain A; Andrus L; Kim D; Whittaker CA; Tan EKW; Thiberge S; Fleming HE; Mancio-Silva L; Rice CM; Bhatia SN
Sci Adv; 2024 Apr; 10(17):eadm9281. PubMed ID: 38657074
[TBL] [Abstract] [Full Text] [Related]
[Next]
